. Hoek-j-van-den, H. C. Boshuizen, L. D. Roorda, G. J. Tijhuis, and M. T. Nurmohamed, , p.372

, Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study, Rheumatol 373 Int, vol.37, pp.487-493, 2017.

A. Abhishek, G. Nakafero, C. Kuo, C. Mallen, W. Zhang et al., Rheumatoid arthritis 375 and excess mortality: down but not out. A primary care cohort study using data from Clinical 376

, Practice Research Datalink. Rheumatology, vol.57, pp.977-981, 2018.

J. A. Avina-zubieta, J. Thomas, M. Sadatsafavi, A. J. Lehman, and D. Lacaille, Risk of incident 378 cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies

, Ann Rheum Dis, vol.71, pp.1524-1529, 2012.

M. Pujades-rodriguez, B. Duyx, S. L. Thomas, D. Stogiannis, A. Rahman et al.,

, Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A 382 Population Record-Linkage Cohort Study in England, PloS One, vol.11, p.151245, 2016.

H. Maradit-kremers, C. S. Crowson, P. J. Nicola, K. V. Ballman, V. L. Roger et al.,

, Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a 385 population-based cohort study, Arthritis Rheum, vol.52, pp.402-411, 2005.

S. L. Lim, C. Lam, V. Segers, D. L. Brutsaert, D. Keulenaer et al., Cardiac endothelium-387 myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection 388 fraction, Eur Heart J, vol.36, pp.2050-2060, 2015.

R. Bordy, P. Totoson, C. Prati, C. Marie, D. Wendling et al., Microvascular endothelial 390 dysfunction in rheumatoid arthritis, Nat Rev Rheumatol, vol.14, pp.404-420, 2018.

P. Totoson, K. Maguin-gaté, C. Prati, D. Wendling, and C. Demougeot, Mechanisms of endothelial 392 dysfunction in rheumatoid arthritis: lessons from animal studies, Arthritis Res Ther, vol.16, p.202, 2014.

. Biliographie,

M. Kahn, Histoire de la polyarthrite rhumatoïde, Rhumatol Prat, pp.18-20

, Polyarthrite rhumatoïde -Définition, Symptômes, Causes. Santepratique.fr

F. Pillon and Y. Michiels, Epidémiologie et physiopathologie de la polyarthrite rhumatoïde, Actual Pharm, 2013.

E. Myasoedova, C. S. Crowson, H. M. Kremers, T. M. Therneau, and S. E. Gabriel, Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Arthritis Rheum, vol.62, issue.6, pp.1576-1582, 2010.

H. Autorité-de-santé, Polyarthrite Rhumatoïde -Recommandations Professionnelles, 2007.

P. Bertin, F. Fagnani, and A. Duburcq, Impact of rheumatoid arthritis on career progression, productivity, and employability: The PRET Study, Joint Bone Spine, vol.82, issue.5, pp.306-311, 2015.

A. Van-der-helm-van-mil, K. Verpoot, F. Breedveld, T. Huizinga, R. Toes et al., The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis, Arthritis Rheum, vol.54, issue.4, pp.1117-1121, 2006.

T. Schaeverbeke, M. Truchetet, and C. Richez, When and where does rheumatoid arthritis begin?, Joint Bone Spine, vol.79, issue.6, pp.550-554, 2012.

I. B. Mcinnes and G. Schett, The Pathogenesis of Rheumatoid Arthritis, N Engl J Med, vol.365, issue.23, pp.2205-2219, 2011.

S. H. Zrour, R. Boumiza, and N. Sakly, The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity, Jt Bone Spine Rev Rhum, vol.77, issue.1, pp.36-40, 2010.

H. Källberg, B. Ding, and L. Padyukov, Smoking is a major preventable risk factor for Rheumatoid arthritis Estimations of risks after various exposures to cigarette smoke, Ann Rheum Dis, vol.70, issue.3, pp.508-511, 2011.

J. Bagaitkar, C. A. Daep, C. K. Patel, D. E. Renaud, D. R. Demuth et al., Tobacco Smoke Augments Porphyromonas gingivalis -Streptococcus gordonii Biofilm Formation, PLoS ONE, vol.6, issue.11, 2011.

, Ite : Pol a th ite rhumatoïde, Collège Français des Enseignants en Rhumatologie (COFER), 2011.

. Accessed, , 2016.

C. Prati, le de l a gi ase da s la pol a th ite hu atoïde. Etude i i o hez le at, 2009.

P. Totoso, D sfo tio e doth liale et pol a th ite hu atoïde : i ti ue d olutio , mécanismes et traitements. Etude chez le rat, 2015.

. Bu-ge, Pla e de l ta e ept da s la p ise e ha ge de la pol a th ite hu atoïde, 2014.

J. S. Smolen, D. Aletaha, and A. Barton, Rheumatoid arthritis, Nat Rev Dis Primer, vol.4, p.18001, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01558198

K. Aho, T. Palosuo, V. Raunio, P. Puska, A. Aromaa et al., When does rheumatoid disease start?, Arthritis Rheum, vol.28, issue.5, pp.485-489, 1985.

S. Rantapää-dahlqvist, B. De-jong, and E. Berglin, Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis Rheum, vol.48, issue.10, pp.2741-2749, 2003.

D. Aletaha, T. Neogi, and A. J. Silman, Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Ann Rheum Dis, vol.69, issue.9, pp.1580-1588, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01557559

C. Daien, C. Hua, and C. Gaujoux-viala, Update of French society for rheumatology recommendations for managing rheumatoid arthritis. Jt Bone Spine Rev Rhum, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02264783

M. Peters, D. Symmons, and D. Mccarey, EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis, Ann Rheum Dis, vol.69, issue.2, pp.325-331, 2010.

B. Combe, Progression in early rheumatoid arthritis, Best Pract Res Clin Rheumatol, vol.23, issue.1, pp.59-69, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01558208

B. Combe and N. Rincheval, Que nous ont apporté les premières an es d tudes d u e oho te de polyarthrites rhumatoïdes débutantes : la cohorte ESPOIR ?, Rev Rhum, vol.81, issue.6, pp.455-459, 2014.

G. Moute-de, M. El, and J. , Pla e de l hog aphie da s la pol a th ite hu atoïde e issio

, Rev Rhum Monogr, vol.82, issue.4, pp.225-232, 2015.

C. Cyteval, MR imaging of the hands in rheumatoid arthritis, J Radiol, vol.91, issue.1, pp.111-119, 2010.

F. Slosman and . Rhumatoïde, Lésions Des Poignets et Des Mains, 2015.

C. Diapothèque and . Cofer, , 2011.

. Cofe', Pol a th ite hu atoïde, P' ; attei te de l a a t-pied, 2011.

. P-e-oo, . Ml, M. A. Hof, H. H. Kupe, M. A. Leeu-e et al., Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, vol.38, issue.1, pp.44-48, 1995.

I. Bouaddi, E. Bad-i-d, and . Hassa-i-a, Les it es d aluatio de la polyarthrite rhumatoïde, Rev Marocaine Rhumatol, issue.19, pp.19-23, 2012.

J. S. Smolen, F. C. Breedveld, and M. H. Schiff, A simplified disease activity index for rheumatoid arthritis for use in clinical practice, Rheumatol Oxf Engl, vol.42, issue.2, pp.244-257, 2003.

D. Aletaha, V. Nell, and T. Stamm, Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score, Arthritis Res Ther, vol.7, issue.4, pp.796-806, 2005.

B. Bruce and J. F. Fries, The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications, Health Qual Life Outcomes, vol.1, p.20, 2003.

S. S. Laev and N. F. Salakhutdinov, Anti-arthritic agents: Progress and potential, Bioorg Med Chem, vol.23, issue.13, pp.3059-3080, 2015.

J. Bullock, S. Rizvi, and A. Saleh, Rheumatoid Arthritis: A Brief Overview of the Treatment, Med Princ Pract Int J Kuwait Univ Health Sci Cent, 2018.

D. Aletaha and J. S. Smolen, Diagnosis and Management of Rheumatoid Arthritis: A Review, JAMA, vol.320, issue.13, pp.1360-1372, 2018.

B. Combe, R. Landewe, and C. I. Daien, 2016 update of the EULAR recommendations for the management of early arthritis, Ann Rheum Dis, vol.76, issue.6, pp.948-959, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01794370

B. Combe, I. Logeart, and M. C. Belkacemi, Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort, Ann Rheum Dis, vol.74, issue.4, pp.724-729, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01044967

A. Jagpal and I. Navarro-millán, Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment, BMC Rheumatol, vol.2, issue.1, p.10, 2018.

P. Ruscitti, P. Cipriani, and V. Liakouli, The occurrence of subclinical and clinical atherosclerosis in rheumatoid arthritis, results from the 3-year, multicenter, prospective, observational, GIRRCS study, Annals of Rheumatic Diseases, vol.78, pp.117-118

A. Ruyssen-witrand, G. Guernec, and D. Nigon, Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes, Ann Rheum Dis, vol.74, issue.9, pp.1676-1683, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01032092

R. Forestier, J. André-vert, and P. Guillez, Non-drug treatment (excluding surgery) in rheumatoid arthritis: clinical practice guidelines, Jt Bone Spine Rev Rhum, vol.76, issue.6, pp.691-698, 2009.

S. Soulaidopoulos, E. Nikiphorou, T. Dimitroulas, and G. D. Kitas, The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis, Front Med, vol.5, 2018.

A. M. El-barbary, M. S. Hussein, E. M. Rageh, H. E. Hamouda, A. A. Wagih et al., Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis, J Rheumatol, vol.38, issue.2, pp.229-235, 2011.

L. Tam, E. K. Li, and Q. Shang, Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial, Scand J Rheumatol, vol.40, issue.6, pp.411-421, 2011.

A. J. Flammer, I. Sudano, and F. Hermann, Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis, Circulation, vol.117, issue.17, pp.2262-2269, 2008.

R. Refaat, M. Salama, A. Meguid, E. , E. Sarha et al., Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats, Eur J Pharmacol, vol.698, issue.1-3, pp.421-428, 2013.

T. Sakuta, Y. Morita, M. Satoh, D. A. Fox, and N. Kashihara, Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers, Arthritis Rheum, vol.62, issue.5, pp.1319-1328, 2010.

F. Verhoeven, N. Tordi, C. Prati, C. Demougeot, F. Mougin et al., Physical activity and rheumatoid arthritis, a systematic review, Ann Rheum Dis, vol.74, issue.Suppl2, p.416, 2015.

M. Pellegrin, L. Mazzolai, A. Berthelot, and P. Laurant, Dysfonction endothéliale et risque a dio as ulai e. L e e i e p ot ge la fo tio e doth liale et prévient la maladie cardiovasculaire, vol.24, pp.63-73, 2009.

G. S. Metsios, A. Stavropoulos-kalinoglou, and A. Sandoo, Vascular function and inflammation in rheumatoid arthritis: the role of physical activity, Open Cardiovasc Med J, vol.4, pp.89-96, 2010.

J. S. Smolen, R. Landewé, and J. Bijlsma, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update, Ann Rheum Dis, vol.76, issue.6, pp.960-977, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01778213

J. A. Singh, K. G. Saag, and S. L. Bridges, American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis, Arthritis Rheumatol Hoboken NJ, vol.68, issue.1, pp.1-26, 2015.

S. Cobb, F. Anderson, and W. Bauer, Length of Life and Cause of Death in Rheumatoid Arthritis, N Engl J Med, vol.249, issue.14, pp.553-556, 1953.

J. A. Aviña-zubieta, H. K. Choi, M. Sadatsafavi, M. Etminan, J. M. Esdaile et al., Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies, Arthritis Rheum, vol.59, issue.12, pp.1690-1697, 2008.

S. Dadoun, N. Zeboulon-ktorza, and C. Combescure, Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis, Joint Bone Spine, vol.80, issue.1, pp.29-33, 2013.

R. Agca, S. C. Heslinga, and S. Rollefstad, EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update, Ann Rheum Dis, pp.2016-209775, 2016.

S. Romano, E. Salustri, P. Ruscitti, F. Carubbi, M. Penco et al., Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis, Curr Rheumatol Rep, vol.20, issue.12, p.81, 2018.

J. Lindhardsen, O. Ahlehoff, and G. H. Gislason, The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study, Ann Rheum Dis, vol.70, issue.6, pp.929-934, 2011.

V. P. Van-halm, M. Peters, and A. E. Voskuyl, Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation, Ann Rheum Dis, vol.68, issue.9, pp.1395-1400, 2009.

M. Peters, V. P. Van-halm, and A. E. Voskuyl, Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study, Arthritis Rheum, vol.61, issue.11, pp.1571-1579, 2009.

J. R. Curtis, S. Yang, and J. A. Singh, Is Rheumatoid Arthritis a Cardiovascular Risk Equivalent to Diabetes? Arthritis Care Res, 2018.

R. Agca, L. Hopman, and K. Laan, Cardiovascular Event Risk in Rheumatoid Arthritis is Higher than in Type 2 Diabetes: a 15 Year Longitudinal Study, J Rheumatol, 2019.

S. M. Naz, T. M. Farragher, D. K. Bunn, D. Symmons, and I. N. Bruce, The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis, Arthritis Rheum, vol.58, issue.4, pp.985-989, 2008.

E. Bartoloni, A. Alunno, O. Bistoni, and R. Gerli, How early is the atherosclerotic risk in rheumatoid arthritis?, Autoimmun Rev, vol.9, issue.10, pp.701-707, 2010.

A. M. Kerola, M. J. Kauppi, T. Kerola, and T. Nieminen, How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?, Ann Rheum Dis, vol.71, issue.10, pp.1606-1615, 2012.

B. J. Radovits, J. Fransen, S. A. Shamma, A. M. Eijsbouts, and R. Riel-plcm-van,-laan, Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis, Arthritis Care Res, vol.62, issue.3, pp.362-370, 2010.

E. Arts, J. Fransen, A. A. Broeder, . Den, C. D. Popa et al., The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients, Ann Rheum Dis, vol.74, issue.6, pp.998-1003, 2014.

E. Myasoedova, A. Chandran, and B. Ilhan, The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease, Ann Rheum Dis, vol.75, issue.3, pp.560-565, 2016.

B. R. England, H. Sayles, and K. Michaud, Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis, Arthritis Care Res, vol.68, issue.1, pp.36-45, 2016.

D. Lacaille, J. A. Avina-zubieta, E. C. Sayre, and M. Abrahamowicz, Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap, Ann Rheum Dis, vol.76, issue.6, pp.1057-1063, 2017.

D. H. Solomon, G. W. Reed, and J. M. Kremer, Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events, Arthritis Rheumatol, vol.67, issue.6, pp.1449-1455, 2015.

J. A. Avina-zubieta, J. Thomas, M. Sadatsafavi, A. J. Lehman, and D. Lacaille, Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies, Ann Rheum Dis, vol.71, issue.9, pp.1524-1529, 2012.

Y. Chen, F. Hsieh, C. Chang, C. Wu, H. Chiou et al., The effect of rheumatoid arthritis on the risk of cerebrovascular disease and coronary artery disease in young adults, J Chin Med Assoc JCMA, vol.81, issue.9, pp.772-780, 2018.

C. Meune, E. Touzé, L. Trinquart, and Y. Allanore, High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis, Arch Cardiovasc Dis, vol.103, issue.4, pp.253-261, 2010.

A. Faccini, J. C. Kaski, and P. G. Camici, Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases, Eur Heart J, vol.37, issue.23, pp.1799-1806, 2016.

R. H. Mackey, L. H. Kuller, and L. W. Moreland, Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases, Rheum Dis Clin North Am, vol.44, issue.3, pp.475-487, 2018.

P. W. Meyer, R. Anderson, J. A. Ker, and M. T. Ally, Rheumatoid arthritis and risk of cardiovascular disease, Cardiovasc J Afr, vol.29, issue.5, pp.317-321, 2018.

F. Buleu, E. Sirbu, A. Caraba, and S. Dragan, Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review, Med Kaunas Lith, vol.55, issue.6, 2019.

M. E. Holmqvist, S. Wedrén, and L. Jacobsson, No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish populationbased rheumatoid arthritis cohorts, Arthritis Rheum, vol.60, issue.10, pp.2861-2869, 2009.

M. E. Holmqvist, S. Wedrén, and L. Jacobsson, Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006, J Intern Med, vol.268, issue.6, pp.578-585, 2010.

M. Pujades-rodriguez, B. Duyx, and S. L. Thomas, Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England, PloS One, vol.11, issue.3, p.151245, 2016.

Ä. Mantel, M. Holmqvist, and F. Nyberg, Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New-Onset Rheumatoid Arthritis: A Nested Case-Control Study, Arthritis Rheumatol, vol.67, issue.11, pp.2845-2854, 2015.

L. Pan and T. Wang, Features of cardiac remodeling in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis, Sci Rep, vol.7, 2017.

P. J. Nicola, H. Maradit-kremers, and V. L. Roger, The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years, Arthritis Rheum, vol.52, issue.2, pp.412-420, 2005.

B. B. Løgstrup, T. Ellingsen, A. B. Pedersen, A. Kjaersgaard, H. Bøtker et al., Development of heart failure in patients with rheumatoid arthritis: A Danish population-based study, Eur J Clin Invest, vol.48, issue.5, p.12915, 2018.

F. Zeng, W. Wen, and W. Cui, Central role of RIPK1-VDAC1 pathway on cardiac impairment in a non-human primate model of rheumatoid arthritis, J Mol Cell Cardiol, vol.125, pp.50-60, 2018.

J. M. Davis, V. L. Roger, C. S. Crowson, H. M. Kremers, T. M. Therneau et al., The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population, Arthritis Rheum, vol.58, issue.9, pp.2603-2611, 2008.

F. Aslam, S. J. Bandeali, N. A. Khan, and M. Alam, Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review, Arthritis Care Res, vol.65, issue.4, pp.534-543, 2013.

E. Myasoedova, J. M. Davis, and C. S. Crowson, Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study, Arthritis Rheum, vol.65, issue.7, pp.1713-1718, 2013.

H. Midtbø, E. Gerdts, and T. K. Kvien, Disease activity and left ventricular structure in patients with rheumatoid arthritis, Rheumatology, vol.54, issue.3, pp.511-519, 2015.

H. Midtbø, A. G. Semb, K. Matre, T. K. Kvien, and E. Gerdts, Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis, Ann Rheum Dis, vol.76, issue.2, pp.371-376, 2017.

I. Amigues, A. Tugcu, and C. Russo, Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET-CT) is Associated with Disease Activity in Rheumatoid Arthritis. Arthritis Rheumatol Hoboken NJ, 2018.

H. Kobayashi, Y. Kobayashi, I. Yokoe, Y. Akashi, M. Takei et al., Magnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels, Arthritis Care Res, vol.69, issue.9, pp.1304-1311, 2017.

M. Biskup, W. Biskup, M. Majda, and T. Go?ska, t?p iak B. Ca dio as ula s ste ha ges i rheumatoid arthritis patients with continued low disease activity, Rheumatol Int, vol.38, issue.7, pp.1207-1215, 2018.

B. Ta-go?ska-"t?p-iak, M. Biskup, W. Biskup, and M. Majda, Diastoli d sfu tio i heu atoid arthritis patients with low disease activity, Clin Rheumatol, 2018.

S. Masoud, P. B. Lim, G. D. Kitas, and V. Panoulas, Sudden cardiac death in patients with rheumatoid arthritis, World J Cardiol, vol.9, issue.7, pp.562-573, 2017.

A. M. Adlan, J. Veldhuijzen-van-zanten, G. Lip, J. Paton, G. D. Kitas et al., Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis, Auton Neurosci, vol.208, pp.137-145, 2017.

C. I. Daïen and P. Fesler,

, Ann Cardiol Angiol, vol.61, issue.2, pp.111-117, 2012.

B. Zöller, X. Li, J. Sundquist, and K. Sundquist, Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden, BMC Neurol, vol.12, p.41, 2012.

S. J. Wiseman, S. H. Ralston, and J. M. Wardlaw, Cerebrovascular Disease in Rheumatic Diseases: A Systematic Review and Meta-Analysis, Stroke, vol.47, issue.4, pp.943-950, 2016.

Y. Chen, F. Hsieh, and L. Lien, Rheumatoid arthritis significantly increased recurrence risk after ischemic stroke/transient ischemic attack, J Neurol, vol.265, issue.8, pp.1810-1818, 2018.

H. Hashimoto, M. Kawamura, and T. Yukami, Etiology of acute ischaemic cerebrovascular disease associated with rheumatoid arthritis: changes with progression of anti-inflammatory therapy, Eur J Neurol, vol.12, pp.1462-1469, 2018.

A. Low, M. Lunt, and L. K. Mercer, Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis, Arthritis Rheumatol Hoboken NJ, vol.68, issue.6, pp.1337-1345, 2016.

M. Dichgans and D. Leys, Vascular Cognitive Impairment, Circ Res, vol.120, issue.3, pp.573-591, 2017.

M. Pedard, C. Demougeot, C. Prati, and C. Marie, Brain-derived neurotrophic factor in adjuvantinduced arthritis in rats. Relationship with inflammation and endothelial dysfunction, Prog Neuropsychopharmacol Biol Psychiatry, vol.82, pp.249-254, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01706776

M. Pedard, A. Quirié, P. Garnier, A. Tessier, C. Demougeot et al., The Cerebral Brain-Derived Neurotrophic Factor Pathway, Either Neuronal or Endothelial, Is Impaired in Rats with Adjuvant-Induced Arthritis. Connection with Endothelial Dysfunction, Front Physiol, vol.8, p.1125, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01681219

T. Meade, N. Manolios, S. R. Cumming, P. G. Conaghan, and P. Katz, Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review, Arthritis Care Res, vol.70, issue.1, pp.39-52, 2018.

M. Bartolini, M. Candela, and M. Brugni, Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study, Clin Exp Rheumatol, vol.20, issue.4, pp.491-497, 2002.

S. Appenzeller, M. B. Bertolo, and L. Costallat, Cognitive impairment in rheumatoid arthritis, Methods Find Exp Clin Pharmacol, vol.26, issue.5, pp.339-343, 2004.

S. Y. Shin, P. Katz, M. Wallhagen, and L. Julian, Cognitive Impairment in Persons With Rheumatoid Arthritis, Arthritis Care Res, vol.64, issue.8, pp.1144-1150, 2012.

F. Atzeni, N. Pipitone, and L. Iaccarino, Rheumatic diseases and autoimmune vascular dementia, Autoimmun Rev, vol.16, issue.12, pp.1265-1269, 2017.

J. H. Lee, G. Kim, Y. Kim, and S. Lee, Cognitive function of patients with rheumatoid arthritis is associated with disease activity but not carotid atherosclerotic changes, Clin Exp Rheumatol, vol.36, issue.5, pp.856-861, 2018.

M. Margaretten, L. Julian, P. Katz, and E. Yelin, Depression in patients with rheumatoid arthritis: description, causes and mechanisms, Int J Clin Rheumatol, vol.6, issue.6, pp.617-623, 2011.

F. Matcham, L. Rayner, S. Steer, and M. Hotopf, The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis, Rheumatol Oxf Engl, vol.52, issue.12, pp.2136-2148, 2013.

T. Tsai, M. Lu, H. Livneh, S. Chiu, N. Lai et al., Does depression increase the risk of stroke in patients with rheumatoid arthritis? A population-based cohort study, BMJ Open, vol.7, issue.4, p.14233, 2017.

A. Farhi, A. D. Cohen, O. Shovman, D. Comaneshter, H. Amital et al., Bipolar disorder associated with rheumatoid arthritis: A case-control study, J Affect Disord, vol.189, pp.287-289, 2016.

C. Tanasescu, C. Jurcut, R. Jurcut, and C. Ginghina, Vascular disease in rheumatoid arthritis: from subclinical lesions to cardiovascular risk, Eur J Intern Med, vol.20, issue.4, pp.348-354, 2009.

O. R. Ghosh-swaby and B. Kuriya, Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review, Arthritis Res Ther, vol.21, issue.1, p.33, 2019.

B. R. England, G. M. Thiele, D. R. Anderson, and T. R. Mikuls, Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications, BMJ, vol.361, p.1036, 2018.

, European Society of Cardiology. SCORE Risk, 2016.

C. S. Crowson, E. L. Matteson, V. L. Roger, T. M. Therneau, and S. E. Gabriel, Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis, Am J Cardiol, vol.110, issue.3, pp.420-424, 2012.

E. Arts, C. Popa, and A. Broeder, Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis, Ann Rheum Dis, vol.74, issue.4, pp.668-674, 2015.

E. Arts, C. D. Popa, and A. Broeder, Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms, Ann Rheum Dis, vol.75, issue.4, pp.674-680, 2016.

C. Gonzalez-martin, G. Morais, S. Pertega-diaz, S. Seoane-pillado, T. Balboa-barreiro et al., Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis, Cardiol Res Pract, p.7689208, 2019.

D. H. Solomon, J. Greenberg, and J. R. Curtis, Derivation and Internal Validation of an Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis: A Consortium of Rheumatology Researchers of North America Registry Study, Arthritis Rheumatol, vol.67, issue.8, pp.1995-2003, 2015.

C. S. Crowson, S. Rollefstad, and G. D. Kitas, Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis, PLOS ONE, vol.12, issue.3, p.174656, 2017.

M. I. Wah-suarez, D. A. Galarza-delgado, and J. R. Azpiri-lopez, The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients, Clin Rheumatol, vol.37, issue.9, pp.2373-2380, 2018.

C. S. Crowson, S. E. Gabriel, and A. G. Semb, Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries, Rheumatology, vol.56, issue.7, pp.1102-1110, 2017.

I. D. Del-rincón, W. K. Stern, M. P. Freeman, G. L. Escalante, and A. , High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors, Arthritis Rheum, vol.44, issue.12, pp.2737-2745, 2001.

M. Soubrier, N. B. Chamoux, Z. Tatar, M. Couderc, J. Dubost et al., Cardiovascular risk in rheumatoid arthritis, Joint Bone Spine, vol.81, issue.4, pp.298-302, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01117207

V. F. Panoulas, K. Douglas, and H. J. Milionis, Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis, Rheumatol Oxf Engl, vol.46, issue.9, pp.1477-1482, 2007.

V. F. Panoulas, G. S. Metsios, and A. V. Pace, Hypertension in rheumatoid arthritis, Rheumatol Oxf Engl, vol.47, issue.9, pp.1286-1298, 2008.

J. Boyer, V. Bongard, and A. Cantagrel, Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: results from a French multicenter cohort, Arthritis Care Res, vol.64, issue.6, pp.872-880, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01557749

. P-otoge-ou, P. Ad, and E. Db, A te ial h pe te sio assessed out-ofoffi e i a o te po a oho t of heu atoid a th itis patie ts f ee of a dio as ula disease is characterized by high prevalence, low awareness, poor control and increased vascular damage, Arthritis Res Ther, vol.15, issue.5, p.142, 2013.

L. R. Baghdadi, R. J. Woodman, E. M. Shanahan, and A. A. Mangoni, The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis, PloS One, vol.10, issue.2, p.117952, 2015.

P. Ruscitti, P. Cipriani, and F. Masedu, Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study, PLOS ONE, vol.12, issue.1, p.170108, 2017.

G. S. Metsios, A. Stavropoulos-kalinoglou, and J. Veldhuijzen-van-zanten, Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review, Rheumatol Oxf Engl, vol.47, issue.3, pp.239-248, 2008.

T. We-e, O. 'ou-ke, M. F. , E. Pu-ze-g-u-e, C. et al., Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction, Am J Hypertens, vol.21, issue.11, pp.1194-1202, 2008.

T. Weber, Systolic and diastolic function as related to arterial stiffness, Artery Res, vol.4, issue.4, pp.122-127, 2010.

J. Plutzky and K. P. Liao, Lipids in RA: What do they mean?, Curr Rheumatol Rep, vol.20, issue.2, p.8, 2018.

E. Myasoedova, C. S. Crowson, and H. M. Kremers, Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease, Ann Rheum Dis, vol.70, issue.3, pp.482-487, 2011.

I. Navarro-millán, Y. S. Duvall, and S. L. , Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration, Ann Rheum Dis, vol.75, issue.2, pp.341-347, 2016.

A. Arida, A. D. Protogerou, G. D. Kitas, and P. P. Sfikakis, Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases, Int J Mol Sci, vol.19, issue.7, p.1890, 2018.

M. Soubrier and M. Dougados, Athérome et polyarthrite rhumatoïde, Rev Médecine Interne, vol.27, pp.125-136, 2006.

M. D. George, J. T. Giles, and P. P. Katz, Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis, Arthritis Care Res, vol.69, issue.12, pp.1789-1798, 2017.

K. Kang, J. C. Sullivan, J. M. Sasser, J. D. Imig, and J. S. Pollock, Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats, Hypertension, vol.49, issue.4, pp.893-901, 2007.

J. N. Hoes, M. C. Van-der-goes, and D. H. Van-raalte, Glucose tolerance, insulin sensitivity and ?cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids, Ann Rheum Dis, vol.70, issue.11, pp.1887-1894, 2011.

M. A. Gonzalez-gay, C. Gonzalez-juanatey, and J. Martin, Rheumatoid Arthritis: A Disease Associated with Accelerated Atherogenesis, Semin Arthritis Rheum, vol.35, issue.1, pp.8-17, 2005.

P. Ambrosino, R. Lupoli, D. Minno, A. Tasso, M. Peluso et al., Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies, Thromb Haemost, vol.113, issue.5, pp.916-930, 2015.

M. Cio-a-u-ju-u?, &. Ju-u?, C. Mih?il?, M. , A. et al., u li i al athe os le osis, carotid intima-media thickness and the cardiovascular risk, Romanian J Intern Med Rev Roum Med Interne, vol.41, issue.4, pp.357-363, 2003.

W. Lorenz-matthias, M. Hugh, S. Bots-michiel, and L. Maria, Sitzer Matthias. Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness, Circulation, vol.115, issue.4, pp.459-467, 2007.

P. N. Tyrrell, J. Beyene, B. M. Feldman, B. W. Mccrindle, E. D. Silverman et al., Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis

, Arterioscler Thromb Vasc Biol, vol.30, issue.5, pp.1014-1026, 2010.

A. Raczkiewicz, A. Juszkiewicz, and B. Kisiel, Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis, Arch Med Sci Atheroscler Dis, vol.1, issue.1, pp.36-43, 2016.

B. Ta-go?ska-"t?p-iak, M. Biskup, W. Biskup, and M. Majda, Ge de Diffe e es i Ca dio as ula Risk Profile in Rheumatoid Arthritis Patients with Low Disease Activity, BioMed Res Int, 2019.

Y. Shoenfeld, R. Gerli, and A. Doria, Accelerated atherosclerosis in autoimmune rheumatic diseases, Circulation, vol.112, issue.21, pp.3337-3347, 2005.

E. E-a-s-m', A. Ala-te, . Battafa-a-o-df, . Gl, and D. H. Lea, 168. del 'i I, F ee a GL, Haas 'W, O Lea DH, Es ala te A. 'elati e o t i utio of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis, Arthritis Rheum, vol.63, issue.5, pp.3413-3423, 2005.

B. Kisiel, R. Kruszewski, and A. Juszkiewicz, Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration, Rheumatol Int, 2018.

A. G. Semb, S. Rollefstad, and S. A. Provan, Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis, J Rheumatol, vol.40, issue.4, pp.359-368, 2013.

C. P. Chung, A. Oeser, and P. Raggi, Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors, Arthritis Rheum, vol.52, issue.10, pp.3045-3053, 2005.

P. D. Chantler and J. C. Frisbee, Arterial function in cardio-metabolic diseases: from the microcirculation to the large conduits, Prog Cardiovasc Dis, vol.57, issue.5, pp.489-496, 2015.

O. Hanon, S. Haulon, and H. Lenoir, Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss, Stroke, vol.36, issue.10, pp.2193-2197, 2005.

L. Y. Chen, M. Leening, and F. L. Norby, Carotid Intima-Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study, J Am Heart Assoc, vol.5, issue.5, 2016.

M. Robustillo-villarino, A. Rodilla-sala, and E. , Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis, Clin Rheumatol, vol.36, issue.11, pp.2601-2606, 2017.

E. Arosio, D. Marchi, S. Rigoni, A. Prior, M. Delva et al., Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis, J Hypertens, vol.25, issue.6, pp.1273-1278, 2007.

K. M. Mäki-petäjä, F. C. Hall, and A. D. Booth, Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy, Circulation, vol.114, issue.11, pp.1185-1192, 2006.

I. Avalos, C. P. Chung, and A. Oeser, Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis, J Rheumatol, vol.34, issue.12, pp.2388-2394, 2007.

S. Kaptoge, D. Angelantonio, and E. , C-reactive protein, fibrinogen, and cardiovascular disease prediction, N Engl J Med, vol.367, issue.14, pp.1310-1320, 2012.

M. A. Gonzalez-gay, C. Gonzalez-juanatey, and M. J. Lopez-diaz, HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis, Arthritis Rheum, vol.57, issue.1, pp.125-132, 2007.

J. Zhang, L. Chen, and E. Delzell, The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis, Ann Rheum Dis, vol.73, issue.7, pp.1301-1308, 2014.

D. E. Moller, Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes, Trends Endocrinol Metab TEM, vol.11, issue.6, pp.212-217, 2000.

B. H. Hahn, J. Grossman, W. Chen, and M. Mcmahon, The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia, J Autoimmun, vol.28, issue.2-3, pp.69-75, 2007.

. Del-'i-i, J. F. Polak, and D. H. Lea, ste i i fla atio a d a dio as ula isk factors predict rapid progression of atherosclerosis in rheumatoid arthritis, Ann Rheum Dis, vol.74, issue.6, pp.1118-1123, 2015.

A. L. Carey and M. A. Febbraio, Interleukin-6 and insulin sensitivity: friend or foe?, Diabetologia, vol.47, issue.7, pp.1135-1142, 2004.

S. A. El-bakry, D. Fayez, and C. S. Morad, Ischemic heart disease and rheumatoid arthritis: Do inflammatory cytokines have a role?, Cytokine, vol.96, pp.228-233, 2017.

O. Ciftci, S. Yilmaz, and S. Topcu, Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis, Atherosclerosis, vol.198, issue.2, pp.332-337, 2008.

K. Kakuta, K. Dohi, and Y. Sato, Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition, J Am Soc Echocardiogr, vol.29, issue.2, pp.173-180, 2016.

C. I. Daïen, P. Fesler, and . Cailar-g-du, Etanercept normalises left ventricular mass in patients with rheumatoid arthritis, Ann Rheum Dis, vol.72, issue.6, pp.881-887, 2013.

I. Ikonomidis, S. Tzortzis, and I. Andreadou, Increased Benefit of Interleukin 1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients with Coronary Artery Disease and Coexisting Rheumatoid Arthritis, Circ Cardiovasc Imaging, vol.7, issue.4, pp.619-628, 2014.

L. Smeeth, S. L. Thomas, A. J. Hall, R. Hubbard, P. Farrington et al., Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination, N Engl J Med, vol.351, issue.25, pp.2611-2618, 2004.

S. K. Mccann, F. Cramond, M. R. Macleod, and E. S. Sena, Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update, Transl Stroke Res, vol.7, issue.5, pp.395-406, 2016.

A. Sobowale-oluwaseun, R. Parry-jones-adrian, S. Craig, J. Tyrrell-pippa, J. Rothwell-nancy et al., Stroke. Stroke, vol.47, issue.8, pp.2160-2167, 2016.

M. S. Madhur, H. E. Lob, and L. A. Mccann, Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction, vol.55, pp.500-507, 1979.

W. Swardfager, D. A. Winer, N. Herrmann, S. Winer, and K. L. Lanctôt, Interleukin-17 in post-stroke neurodegeneration, Neurosci Biobehav Rev, vol.37, issue.3, pp.436-447, 2013.

L. Nerurkar, S. Siebert, I. B. Mcinnes, and J. Cavanagh, Rheumatoid arthritis and depression: an inflammatory perspective, Lancet Psychiatry, vol.6, issue.2, pp.30255-30259, 2019.

C. Roubille, V. Richer, and T. Starnino, The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis, Ann Rheum Dis, vol.74, issue.3, pp.480-489, 2015.

H. Tam, C. Chen, and P. Leong, Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study, Int J Rheum Dis, vol.21, issue.8, pp.1591-1599, 2018.

F. Matcham, J. Galloway, and M. Hotopf, The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health: A Systematic Review and Network Meta-Analysis, Arthritis Rheumatol, vol.70, issue.9, pp.1377-1391, 2018.

S. Chandra, M. J. Romero, A. Shatanawi, A. M. Alkilany, R. B. Caldwell et al., Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway, Br J Pharmacol, vol.165, issue.2, pp.506-519, 2012.

C. S. Crowson, S. Rollefstad, and E. Ikdahl, Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis, Ann Rheum Dis, vol.77, issue.1, pp.48-54, 2018.

S. Skeoch and I. N. Bruce, Atherosclerosis in rheumatoid arthritis: is it all about inflammation?, Nat Rev Rheumatol, vol.11, issue.7, pp.390-400, 2015.

E. Bartoloni, A. Alunno, and V. Valentini, Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality? Front Cardiovasc Med, vol.5, 2018.

N. Ronda, D. Greco, and M. P. Adorni, Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism, Arthritis Rheumatol Hoboken NJ, vol.67, issue.5, pp.1155-1164, 2015.

C. Qiu, X. Zhao, Q. Zhou, and Z. Zhang, High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis, Lipids Health Dis, vol.16, issue.1, p.212, 2017.

J. Teramachi, A. Kukita, and Y. Li, Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis, Lab Investig J Tech Methods Pathol, vol.91, issue.5, pp.719-731, 2011.

C. C. Thornton, F. Al-rashed, and D. Calay, Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation, Ann Rheum Dis, 2015.

. B?l?-es-u-a-', . Boji-?-vc, and . Boji-?-m, B?l? es u "M. Ca dio as ula effe ts of methotrexate in immune-mediated inflammatory diseases, Exp Ther Med, vol.17, issue.2, pp.1024-1029, 2019.

S. Mathieu, B. Pereira, A. Tournadre, and M. Soubrier, Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis, Ann Rheum Dis, vol.77, issue.10, p.65, 2018.

C. Vlachopoulos, A. Gravos, and G. Georgiopoulos, The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis, Clin Rheumatol, vol.37, issue.2, pp.515-526, 2018.

N. Ntusi, J. M. Francis, and E. Sever, Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases, Int J Cardiol, vol.270, pp.253-259, 2018.

C. I. Daïen, Y. Duny, T. Barnetche, J. Daurès, B. Combe et al., Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis, Ann Rheum Dis, vol.71, issue.6, pp.862-868, 2012.

F. C. Huvers, C. Popa, M. G. Netea, F. Van-den-hoogen, and C. J. Tack, Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases, Ann Rheum Dis, vol.66, issue.4, pp.558-559, 2007.

T. Kadokami, C. Frye, B. Lemster, C. L. Wagner, A. M. Feldman et al., Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model, Circulation, vol.104, issue.10, pp.1094-1097, 2001.

D. L. Mann, J. Mcmurray, and M. Packer, Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL), Circulation, vol.109, issue.13, pp.1594-1602, 2004.

E. S. Chung, M. Packer, K. H. Lo, A. A. Fasanmade, and J. T. Willerson, Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial, Circulation, vol.107, issue.25, pp.3133-3140, 2003.

N. R. Bonetti, C. Diaz-cañestro, and L. Liberale, Tumour Necrosis Factor-? Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis, Sci Rep, vol.9, 2019.

A. Deb, N. Dwibedi, T. Lemasters, J. A. Hornsby, W. Wei et al., Tumor Necrosis Factor Inhibitor Therapy and the Risk for Depression Among Working-Age Adults with Rheumatoid Arthritis, Am Health Drug Benefits, vol.12, issue.1, pp.30-38, 2019.

A. Souto, E. Salgado, J. R. Maneiro, A. Mera, L. Carmona et al., Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis, Arthritis Rheumatol Hoboken NJ, vol.67, issue.1, pp.117-127, 2015.

C. Gabay, I. B. Mcinnes, and A. Kavanaugh, Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis, Ann Rheum Dis, vol.75, issue.10, pp.1806-1812, 2016.

S. C. Kim, D. H. Solomon, and J. R. Rogers, Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study, Arthritis Rheumatol, vol.69, issue.6, pp.1154-1164, 2017.

P. Ruiz-limón, R. Ortega, and . Rosa-ia-de-la, Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation, Transl Res, vol.183, pp.87-103, 2017.

A. Fioravanti, S. Tenti, and M. R. Bacarelli, Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition, Clin Exp Rheumatol, 2018.

K. Kume, K. Amano, S. Yamada, K. Hatta, H. Ohta et al., Tocilizumab Monotherapy Reduces Arterial Stiffness as Effectively as Etanercept or Adalimumab Monotherapy in Rheumatoid Arthritis: An Open-label Randomized Controlled Trial, J Rheumatol, vol.38, issue.10, pp.2169-2171, 2011.

S. Mathieu, M. Couderc, and B. Glace, Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis, Biol Targets Ther, vol.7, pp.259-264, 2013.

D. S. Novikova, T. V. Popkova, and G. V. Lukina, The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis, J Korean Med Sci, vol.31, issue.2, pp.202-207, 2016.

G. Kerekes, P. Soltész, and H. Dér, Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis, Clin Rheumatol, vol.28, issue.6, pp.705-710, 2009.

S. Mathieu, B. Pereira, J. Dubost, J. Lusson, and M. Soubrier, No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment, Rheumatol Oxf Engl, vol.51, issue.6, pp.1107-1111, 2012.

R. F. Van-vollenhoven, R. Fleischmann, and S. Cohen, Tofacitinib or adalimumab versus placebo in rheumatoid arthritis, N Engl J Med, vol.367, issue.6, pp.508-519, 2012.

K. Kume, K. Amano, and S. Yamada, Tofacitinib improves atherosclerosis despite upregulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study, Rheumatol Int, vol.37, issue.12, pp.2079-2085, 2017.

C. Qiu, X. Zhao, and L. She, Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials, Lipids Health Dis, vol.18, issue.1, p.54, 2019.

W. Xie, Y. Huang, X. S. Sun, X. Fan, Y. Zhang et al., Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and metaanalysis of randomised controlled trials, Ann Rheum Dis, 2019.

S. E. Nissen, N. D. Yeomans, and D. H. Solomon, Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis, N Engl J Med, vol.375, issue.26, pp.2519-2529, 2016.

J. Lindhardsen, G. H. Gislason, and S. Jacobsen, Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study, Ann Rheum Dis, vol.73, issue.8, pp.1515-1521, 2014.

Y. Chen, F. Hsieh, C. Chang, C. Wu, H. Chiou et al., Effect on Risk of Stroke and Acute Myocardial Infarction of Nonselective Nonsteroidal Anti-Inflammatory Drugs in Patients With Rheumatoid Arthritis, Am J Cardiol, vol.121, issue.10, pp.1271-1277, 2018.

, New safety advice for diclofenac -CMDh endorses PRAC recommendation, 2018.

, PRAC recommends updating advice on use of high-dose ibuprofen | European Medicines Agency

I. Del-rincón, D. F. Battafarano, J. F. Restrepo, J. M. Erikson, and A. Escalante, Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis, Arthritis Rheumatol Hoboken NJ, vol.66, issue.2, pp.264-272, 2014.

J. Zhang, F. Xie, and H. Yun, Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis, Ann Rheum Dis, vol.75, issue.10, pp.1813-1818, 2016.

J. M. Davis, M. Kremers, H. Crowson, and C. S. , Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study, Arthritis Rheum, vol.56, issue.3, pp.820-830, 2007.

B. W. Wong, A. Meredith, D. Lin, and B. M. Mcmanus, The biological role of inflammation in atherosclerosis, Can J Cardiol, vol.28, issue.6, pp.631-641, 2012.

J. An, E. Alemao, and K. Reynolds, Cardiovascular Outcomes Associated with Lowering Lowdensity Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis, J Rheumatol, vol.43, issue.11, pp.1989-1996, 2016.

G. D. Kitas, P. Nightingale, and J. Armitage, Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA): A multicenter, randomized, placebo controlled trial. Arthritis Rheumatol Hoboken NJ, 2019.

M. Vera, H. Choi, M. Abrahamowicz, J. Kopec, and D. Lacaille, Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: A population-based study, Arthritis Care Res, vol.64, issue.6, pp.809-816, 2012.

C. Charles-schoeman, D. Khanna, and D. E. Furst, Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study, J Rheumatol, vol.34, issue.7, pp.1459-1464, 2007.

R. S. Rosenson, J. D. Otvos, and J. Hsia, Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study, Diabetes Care, vol.32, issue.6, pp.1087-1091, 2009.

S. Rollefstad, E. Ikdahl, and J. Hisdal, Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study, Arthritis Rheumatol, vol.67, issue.7, pp.1718-1728, 2015.

E. Ikdahl, S. Rollefstad, and J. Hisdal, Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study, PLOS ONE, vol.11, issue.4, p.153440, 2016.

Y. Haruna, Y. Morita, T. Yada, M. Satoh, D. A. Fox et al., Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis, Arthritis Rheum, vol.56, issue.6, pp.1827-1835, 2007.

P. M. Ridker, E. Danielson, and F. Fonseca, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, vol.359, issue.21, pp.2195-2207, 2008.

I. Navarro-millán, C. Charles-schoeman, and S. Yang, Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial, Arthritis Rheum, vol.65, issue.6, pp.1430-1438, 2013.

T. E. Toms, V. F. Panoulas, and K. Douglas, Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?, Angiology, vol.62, issue.2, pp.167-175, 2011.

M. Peters, A. E. Voskuyl, N. Sattar, B. Dijkmans, .. C. Smulders et al., The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better, Int J Clin Pract, vol.64, issue.10, pp.1440-1443, 2010.

S. S. Khoja, G. J. Almeida, C. Wasko, M. Terhorst, L. Piva et al., Association of Light-Intensity Physical Activity With Lower Cardiovascular Disease Risk Burden in Rheumatoid Arthritis, Arthritis Care Res, vol.68, issue.4, pp.424-431, 2016.

G. S. Metsios, A. Stavropoulos-kalinoglou, and J. Veldhuijzen-van-zanten, Individualised exercise improves endothelial function in patients with rheumatoid arthritis, Ann Rheum Dis, vol.73, issue.4, pp.748-751, 2014.

A. Stavropoulos-kalinoglou, G. S. Metsios, J. Veldhuijzen-van-zanten, P. Nightingale, G. D. Kitas et al., Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis, Ann Rheum Dis, vol.72, issue.11, pp.1819-1825, 2013.

Y. Matsuzawa, T. Kwon, R. J. Lennon, L. O. Lerman, and A. Lerman, Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis, J Am Heart Assoc, vol.4, issue.11, 2015.

D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei, Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease, Diabetes Care, vol.32, issue.2, pp.314-321, 2009.

C. Prati, C. Demougeot, X. Guillot, M. Godfrin-valnet, and D. Wendling, Endothelial dysfunction in joint disease, Joint Bone Spine, vol.81, issue.5, pp.386-391, 2014.

E. N. Marieb and K. Hoehn, Anatomie et Physiologie Humaines. 4e édition. ERPI -Le Renouveau Pédagogique Editions, 2013.

L. Ghitescu and M. Robert, Diversity in unity: The biochemical composition of the endothelial cell surface varies between the vascular beds, Microsc Res Tech, vol.57, issue.5, pp.381-389, 2002.

E. H. Serné, R. T. De-jongh, E. C. Eringa, R. G. Ijzerman, and C. Stehouwer, Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. Hypertens Dallas Tex, vol.50, pp.204-211, 1979.

H. F. Galley and N. R. Webster, Physiology of the endothelium, Br J Anaesth, vol.93, issue.1, pp.105-113, 2004.

P. Totoson, K. Maguin-gaté, C. Prati, D. Wendling, and C. Demougeot, Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies, Arthritis Res Ther, vol.16, issue.1, p.202, 2014.

P. M. Vanhoutte, H. Shimokawa, M. Feletou, and E. Tang, Endothelial dysfunction and vascular disease -a 30th anniversary update, Acta Physiol Oxf Engl, vol.219, issue.1, pp.22-96, 2017.

N. Sennequier and V. Goff, Bios th se du o o de d azote NON : a is e, régulation et contrôle, Médecin/Sciences, vol.14, issue.11, pp.1185-1195, 1998.

D. Li, E. Y. Hayden, and K. Panda, Regulation of the monomer-dimer equilibrium in inducible nitric-oxide synthase by nitric oxide, J Biol Chem, vol.281, issue.12, pp.8197-8204, 2006.

S. Luo, H. Lei, H. Qin, and Y. Xia, Molecular mechanisms of endothelial NO synthase uncoupling, Curr Pharm Des, vol.20, issue.22, pp.3548-3553, 2014.

R. J. Gryglewski, Prostacyclin among prostanoids, Pharmacol Rep PR, vol.60, issue.1, pp.3-11, 2008.

J. Kawabe, F. Ushikubi, and N. Hasebe, Prostacyclin in vascular diseases. -Recent insights and future perspectives, Circ J Off J Jpn Circ Soc, vol.74, issue.5, pp.836-843, 2010.

G. Edwards, M. Félétou, and A. H. Weston, Endothelium-derived hyperpolarising factors and associated pathways: a synopsis, Pflüg Arch Eur J Physiol, vol.459, issue.6, pp.863-879, 2010.

W. C. Aird, Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms, Circ Res, vol.100, issue.2, pp.158-173, 2007.

W. C. Aird, Phenotypic heterogeneity of the endothelium: II. Representative vascular beds, Circ Res, vol.100, issue.2, pp.174-190, 2007.

L. Luksha, S. Agewall, and K. Kublickiene, Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease, Atherosclerosis, vol.202, issue.2, pp.330-344, 2009.

A. Ouattara, Partie I -Physiologie cardio-i ulatoi e ; Chapit e -Physiologie de la circulation coronaire, Physiologie Humaine Appliquée. 2ème. Arnette, vol.2017, pp.83-88

Y. Nishikawa, D. W. Stepp, and W. M. Chilian, Nitric oxide exerts feedback inhibition on EDHFinduced coronary arteriolar dilation in vivo, Am J Physiol Heart Circ Physiol, vol.279, issue.2, pp.459-465, 2000.

Y. Nishikawa, D. W. Stepp, and W. M. Chilian, In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation, Am J Physiol, vol.277, issue.3, pp.1252-1259, 1999.

D. J. Duncker, N. S. Van-zon, T. J. Pavek, S. K. Herrlinger, and R. J. Bache, Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade, J Clin Invest, vol.95, issue.1, pp.285-295, 1995.

G. Florence, La physiologie de la circulation cérébrale, Bull Académie Vét Fr, vol.157, issue.3, pp.19-30, 2004.

M. J. Cipolla, Morgan & Claypool Life Sciences, 2009.

L. Velly, N. Bruder, and I. V. Partie, Physiologie Humaine Appliquée. 2ème. Arnette, vol.2017, pp.627-643

A. , Circle Of Willis: Anatomy, Diag a A d Fu tio s, ie e ABC. Sci ABC, 2017.

R. M. Lee, Morphology of cerebral arteries, Pharmacol Ther, vol.66, issue.1, pp.149-173, 1995.

F. M. Faraci and J. E. Brian, Nitric oxide and the cerebral circulation, Stroke, vol.25, issue.3, pp.692-703, 1994.

E. C. Peterson, Z. Wang, and G. Britz, Regulation of Cerebral Blood Flow, International Journal of Vascular Medicine

M. T. Nelson and J. M. Quayle, Physiological roles and properties of potassium channels in arterial smooth muscle, Am J Physiol, vol.268, issue.4, pp.799-822, 1995.

W. S. Park, Y. K. Son, and N. Kim, Direct modulation of Ca2+-activated K+ current by H-89 in rabbit coronary arterial smooth muscle cells, Vascul Pharmacol, vol.46, issue.2, pp.105-113, 2007.

R. L. Grubb, M. E. Raichle, M. E. Phelps, and R. A. Ratcheson, Effects of increased intracranial pressure on cerebral blood volume, blood flow, and oxygen utilization in monkeys, J Neurosurg, vol.43, issue.4, pp.385-398, 1975.

R. Bergholm, M. Leirisalo-repo, S. Vehkavaara, S. Mäkimattila, M. Taskinen et al., Impaired Responsiveness to NO in Newly Diagnosed Patients With Rheumatoid Arthritis, Arterioscler Thromb Vasc Biol, vol.22, issue.10, pp.1637-1641, 2002.

C. González-juanatey, J. Llorca, and G. Ma, Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease, Arthritis Res Ther, vol.13, issue.3, p.101, 2011.

C. Prati, A. Berthelot, D. Wendling, and C. Demougeot, Endothelial dysfunction in rat adjuvantinduced arthritis: up-regulation of the vascular arginase pathway, Arthritis Rheum, vol.63, issue.8, pp.2309-2317, 2011.

G. Murdaca, B. M. Colombo, P. Cagnati, R. Gulli, F. Spanò et al., Endothelial dysfunction in rheumatic autoimmune diseases, Atherosclerosis, vol.224, issue.2, pp.309-317, 2012.

A. Sandoo, J. Veldhuijzen-van-zanten, G. S. Metsios, D. Carroll, and G. D. Kitas, Vascular function and morphology in rheumatoid arthritis: a systematic review, Semin Arthritis Rheum, vol.50, issue.11, pp.669-675, 2011.

M. A. Alomari, E. F. Keewan, R. A. Shammaa, K. Alawneh, S. Y. Khatib et al., Vascular function and handgrip strength in rheumatoid arthritis patients, ScientificWorldJournal, p.580863, 2012.

P. Anyfanti, A. Triantafyllou, and E. Gkaliagkousi, Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors, Clin Rheumatol, vol.36, issue.6, pp.1229-1236, 2017.

C. Oláh, Z. Kardos, and M. Sepsi, Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis, Arthritis Res Ther, vol.19, issue.1, p.213, 2017.

F. Khan, B. Galarraga, and J. Belch, The role of endothelial function and its assessment in rheumatoid arthritis, Nat Rev Rheumatol, vol.6, issue.5, pp.253-261, 2010.

A. J. Flammer, T. Anderson, and D. S. Celermajer, The assessment of endothelial function: from research into clinical practice, Circulation, vol.126, issue.6, pp.753-767, 2012.

R. Schubert, Isolated Vessels, Practical Methods in Cardiovascular Research, pp.198-211, 2005.

D. Hürlimann, A. Forster, and G. Noll, Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis, Circulation, vol.106, issue.17, pp.2184-2187, 2002.

G. Vaudo, S. Marchesi, and R. Gerli, Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity, Ann Rheum Dis, vol.63, issue.1, pp.31-35, 2004.

L. Moroni, C. Selmi, C. Angelini, and P. L. Meroni, Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic Disease, Arch Immunol Ther Exp (Warsz), vol.65, issue.6, pp.463-475, 2017.

D. Minno, M. Ambrosino, P. Lupoli, and R. , Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies, Eur J Intern Med, vol.26, issue.10, pp.835-842, 2015.

S. Xu, P. Wang, and S. Guan, Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis, Postgrad Med J, vol.93, pp.260-265, 1099.

M. Adawi, A. Watad, and N. L. Bragazzi, Endothelial function in rheumatoid arthritis, QJM Mon J Assoc Physicians, vol.111, issue.4, pp.243-247, 2018.

S. Bosello, A. Santoliquido, and A. Zoli, TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis, Clin Rheumatol, vol.27, issue.7, pp.833-839, 2008.

. C-pie-?-a, J. Dado-ie-?, and &. , The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus, Med Kaunas Lith, vol.46, issue.8, pp.522-530, 2010.

C. Fan, Z. Zhang, Y. Mei, C. Wu, and B. Shen, Impaired brachial artery flow-mediated dilation and increased carotid intima-media thickness in rheumatoid arthritis patients, Chin Med J (Engl), vol.125, issue.5, pp.832-837, 2012.

W. Foster, D. Carruthers, G. Lip, and A. D. Blann, Inflammation and Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Effect of Treatment, J Rheumatol, vol.37, issue.4, pp.711-716, 2010.

W. Foster, G. Lip, K. Raza, D. Carruthers, and A. D. Blann, An observational study of endothelial function in early arthritis, Eur J Clin Invest, vol.42, issue.5, pp.510-516, 2012.

S. Hannawi, T. H. Marwick, and R. Thomas, Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis, Arthritis Res Ther, vol.11, issue.2, p.51, 2009.

M. V. Holmes, B. Jiang, and K. Mcneill, Paradoxical association of C-reactive protein with endothelial function in rheumatoid arthritis, PloS One, vol.5, issue.4, p.10242, 2010.

C. Irace, G. Mancuso, E. Fiaschi, A. Madia, G. Sesti et al., Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol, Atherosclerosis, vol.177, issue.1, pp.113-118, 2004.

G. Kerekes, Z. Szekanecz, and H. Dér, Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity, J Rheumatol, vol.35, issue.3, pp.398-406, 2008.

A. D. Protogerou, E. Zampeli, K. Fragiadaki, K. Stamatelopoulos, C. Papamichael et al., A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis, Atherosclerosis, vol.219, issue.2, pp.734-736, 2011.

B. Sarli, A. O. Baktir, and M. Cebicci, Predictors of endothelial dysfunction in patients with rheumatoid arthritis, Angiology, vol.65, issue.9, pp.778-782, 2014.

A. Södergren, K. Karp, and K. Boman, Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness, Arthritis Res Ther, vol.12, issue.4, p.158, 2010.

F. R. Spinelli, D. Franco, M. Metere, and A. , Decrease of asymmetric dimethyl arginine after anti-TNF therapy in patients with rheumatoid arthritis, Drug Dev Res, vol.75, issue.1, pp.67-69, 2014.

K. S. Stamatelopoulos, G. D. Kitas, and C. M. Papamichael, Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study, Arterioscler Thromb Vasc Biol, vol.29, issue.10, pp.1702-1708, 2009.

A. Temiz, F. Gökmen, and E. Gazi, Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: Associations in rheumatoid arthritis patients, Herz, vol.40, issue.3, pp.217-224, 2015.

S. Van-doornum, G. Mccoll, A. Jenkins, D. J. Green, and I. P. Wicks, Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function, Arthritis Rheum, vol.48, issue.1, pp.72-80, 2003.

I. Verma, A. Syngle, and P. Krishan, Predictors of endothelial dysfunction and atherosclerosis in rheumatoid arthritis in Indian population, Indian Heart J, vol.69, issue.2, pp.200-206, 2017.

M. V. Veselinovic, V. I. Zivkovic, and S. Toncev, Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis, VASA Z Gefasskrankheiten, vol.41, issue.5, pp.343-351, 2012.

E. Pingiotti, P. Cipriani, and A. Marrelli, Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage, Ann N Y Acad Sci, vol.1107, pp.32-41, 2007.

A. Sandoo, G. D. Kitas, D. Carroll, and J. Veldhuijzen-van-zanten, The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study, Arthritis Res Ther, vol.14, issue.3, p.117, 2012.

A. Sandoo, T. Dimitroulas, and T. E. Toms, Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis, Clin Biochem, vol.45, pp.1399-1403, 2012.

M. A. González-gay, G. , and C. , Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis, Arthritis Res Ther, vol.14, issue.4, p.122, 2012.

P. Libby, P. M. Ridker, and A. Maseri, Inflammation and atherosclerosis, Circulation, vol.105, issue.9, pp.1135-1143, 2002.

A. Sandoo, N. Chanchlani, J. Hodson, J. P. Smith, K. M. Douglas et al., Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study, Arthritis Res Ther, vol.15, issue.6, p.203, 2013.

M. Wong, L. Toh, and A. Wilson, Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation, Arthritis Rheum, vol.48, issue.1, pp.81-89, 2003.

A. Arida, E. Zampeli, and G. Konstantonis, Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors, Clin Rheumatol, vol.34, issue.5, pp.853-859, 2015.

C. Gonzalez-juanatey, A. Testa, and A. Garcia-castelo, HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis, Am J Med, vol.114, issue.8, pp.647-652, 2003.

L. Rodríguez-rodríguez, C. González-juanatey, and &. Palomino-mo-ales, TNFA ? (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis, Atherosclerosis, vol.216, issue.1, pp.125-130, 2011.

R. Palomino-morales, C. Gonzalez-juanatey, and T. R. Vazquez-rodriguez, Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis, Clin Exp Rheumatol, vol.27, issue.6, pp.964-970, 2009.

R. Palomino-morales, C. Gonzalez-juanatey, and T. R. Vazquez-rodriguez, A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis, Arthritis Res Ther, vol.12, issue.2, p.71, 2010.

Y. Luo, Y. Wang, and W. Luo, C allele of -786 T>C polymorphism in the promoter region of endothelial nitric oxide synthase is responsible for endothelial dysfunction in the patients with rheumatoid arthritis, J Cell Biochem, 2019.

P. H. Dessein, B. I. Joffe, and S. Singh, Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis, Arthritis Res Ther, vol.7, issue.3, pp.634-643, 2005.

G. Hjeltnes, I. Hollan, Ø. Førre, A. Wiik, K. Mikkelsen et al., predictors of impaired endothelial function in rheumatoid arthritis patients, Scand J Rheumatol, vol.40, issue.6, pp.422-427, 2011.

E. Rollet-labelle, M. Vaillancourt, L. Marois, M. M. Newkirk, P. E. Poubelle et al., Crosslinking of IgGs bound on circulating neutrophils leads to an activation of endothelial cells: possible role of rheumatoid factors in rheumatoid arthritis-associated vascular dysfunction, J Inflamm Lond Engl, vol.10, p.27, 2013.

S. Mateen, A. Zafar, S. Moin, A. Q. Khan, and S. Zubair, Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis, Clin Chim Acta Int J Clin Chem, vol.455, pp.161-171, 2016.

X. Yang, Y. Chang, and W. Wei, Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis, Mediators Inflamm, p.6813016, 2016.

L. J. Crofford, COX-1 and COX-2 tissue expression: implications and predictions, J Rheumatol Suppl, vol.49, pp.15-19, 1997.

E. E. Eriksson, E. Karlof, K. Lundmark, P. Rotzius, U. Hedin et al., Powerful inflammatory properties of large vein endothelium in vivo, Arterioscler Thromb Vasc Biol, vol.25, issue.4, pp.723-728, 2005.

T. Nabe, Interleukin (IL)-33: new therapeutic target for atopic diseases, J Pharmacol Sci, vol.126, issue.2, pp.85-91, 2014.

M. Wu, C. Li, M. Hou, and P. Chu, New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis, Int J Mol Sci, vol.18, issue.10, 2017.

M. Turiel, L. Tomasoni, and S. Sitia, Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis, Cardiovasc Ther, vol.28, issue.5, pp.53-64, 2010.

D. Franco, M. Lucchino, B. Conti, F. Valesini, G. Spinelli et al., Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis, Mediators of Inflammation

N. ?e-tü-k-t, G. Köseo?lu, and K. , Ye ise Ç. 'elatio ship et ee as et i dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis, Eur J Rheumatol, vol.3, issue.3, pp.106-108, 2016.

A. Sandoo, T. Dimitroulas, and J. Veldhuijzen-van-zanten, Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis, Clin Exp Rheumatol, vol.30, issue.3, pp.388-396, 2012.

T. Dimitroulas, A. Sandoo, J. Hodson, J. P. Smith, and G. D. Kitas, In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort, Scand J Clin Lab Invest, vol.76, issue.4, pp.331-337, 2016.

X. Huang, L. Zhang, Y. Duan, Y. Wang, and J. Wang, Association of Pentraxin 3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis, Arch Med Res, vol.47, issue.3, pp.223-231, 2016.

G. Deyab, I. Hokstad, and J. E. Whist, Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, PloS One, vol.12, issue.2, p.169830, 2017.

I. Ca-a-a-a,-c-i?a-v,-'o-o?a and I. Mozo?, Mu a iu M. Vita i D "tatus, Disease A ti it , a d Endothelial Dysfunction in Early Rheumatoid Arthritis Patients, Dis Markers, p.5241012, 2017.

?. Ap-a?-bilge and A. Kal-o-u-u,-e-de, Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional 199

, atherosclerosis risk factors, vol.46, pp.358-365, 2018.

G. Murdaca, F. Spanò, P. Cagnati, and F. Puppo, Free radicals and endothelial dysfunction: potential positive effects of TNF-? inhibitors, Redox Rep Commun Free Radic Res, vol.18, issue.3, pp.95-99, 2013.

K. Kotani, M. Miyamoto, and H. Ando, The Effect of Treatments for Rheumatoid Arthritis on Endothelial Dysfunction Evaluated by Flow-Mediated Vasodilation in Patients with Rheumatoid Arthritis, Curr Vasc Pharmacol, vol.15, issue.1, pp.10-18, 2017.

F. Ursini, C. Leporini, and F. Bene, Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis, Sci Rep, vol.7, issue.1, p.5346, 2017.

S. Mathieu, M. Couderc, B. Pereira, and M. Soubrier, The effects of TNF-alpha inhibitor therapy on arterial stiffness and endothelial dysfunction in rheumatoid arthritis: a meta-analysis, Semin Arthritis Rheum, vol.43, issue.3, pp.1-2, 2013.

P. I. Sidiropoulos, P. Siakka, and K. Pagonidis, Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients, Scand J Rheumatol, vol.38, issue.1, pp.6-10, 2009.

R. Dulai, M. Perry, R. Twycross-lewis, D. Morrissey, F. Atzeni et al., The Effect of Tumor Necrosis Factor-? Antagonists on Arterial Stiffness in Rheumatoid Arthritis: A Literature Review, Semin Arthritis Rheum, vol.42, issue.1, pp.1-8, 2012.

P. Y. Hsue, R. Scherzer, and C. Grunfeld, Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis, J Am Heart Assoc, vol.3, issue.5, p.1267, 2014.

C. Gonzalez-juanatey, J. Llorca, T. R. Vazquez-rodriguez, N. Diaz-varela, H. Garcia-quiroga et al., Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy, Arthritis Rheum, vol.59, issue.12, pp.1821-1824, 2008.

M. Benucci, G. Saviola, M. Manfredi, P. Sarzi-puttini, and F. Atzeni, Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis, Biol Targets Ther, vol.7, pp.69-75, 2013.

I. Ikonomidis, J. P. Lekakis, and M. Nikolaou, Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis, Circulation, vol.117, issue.20, pp.2662-2669, 2008.

M. Benucci, F. Bandinelli, and A. Damiani, Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis, J Inflamm Res, vol.11, pp.247-252, 2018.

A. Sandoo and G. D. Kitas, The impact of abatacept treatment on the vasculature in patients with rheumatoid arthritis, Clin Exp Rheumatol, vol.33, issue.4, p.589, 2015.

F. Verhoeven, C. Prati, K. Maguin-gaté, D. Wendling, and C. Demougeot, Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis, Arthritis Res Ther, vol.18, 2016.

M. Wong, B. Y. Jiang, K. Mcneill, S. Farish, B. Kirkham et al., Effects of selective and non-selective cyclo-oxygenase inhibition on endothelial function in patients with rheumatoid arthritis, Scand J Rheumatol, vol.36, issue.4, pp.265-269, 2007.

K. M. Mäki-petäjä, A. D. Booth, and F. C. Hall, Ezetimibe and Simvastatin Reduce Inflammation, Disease Activity, and Aortic Stiffness and Improve Endothelial Function in Rheumatoid Arthritis, J Am Coll Cardiol, vol.50, issue.9, pp.852-858, 2007.

C. Tikiz, O. Utuk, and T. Pirildar, Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis, J Rheumatol, vol.32, issue.11, pp.2095-2101, 2005.

M. Wahba, B. Messiha, M. El-daly, and A. A. Abo-saif, Vardenafil and cilostazol can improve vascular reactivity in rats with diabetes mellitus and rheumatoid arthritis co-morbidity, Life Sci, 2019.

B. D. Fis-he, A. , A. Lea, and M. E. , Botta o A. A i al odels of heu atoid pai : experimental systems and insights, Arthritis Res Ther, vol.19, 2017.

N. Choudhary, L. K. Bhatt, and K. S. Prabhavalkar, Experimental animal models for rheumatoid arthritis, Immunopharmacol Immunotoxicol, vol.40, issue.3, pp.193-200, 2018.

M. Hegen, J. C. Keith, M. Collins, and C. L. Nickerson-nutter, Utility of animal models for identification of potential therapeutics for rheumatoid arthritis, Ann Rheum Dis, vol.67, issue.11, pp.1505-1515, 2008.

B. Bolon, M. Stolina, and C. King, Rodent Preclinical Models for Developing Novel Antiarthritic Molecules: Comparative Biology and Preferred Methods for Evaluating Efficacy, Rodent Preclinical Models for Developing Novel Antiarthritic Molecules: Comparative Biology and Preferred Methods for Evaluating Efficacy, BioMed Res Int BioMed Res Int, p.569068, 2010.

C. M. Pearson, Development of arthritis, periarthritis and periostitis in rats given adjuvants, Proc Soc Exp Biol Med Soc Exp Biol Med N Y N, vol.91, issue.1, pp.95-101, 1956.

R. P. Gomes, E. Bressan, T. M. Silva, . Da, S. Gevaerd-m-da et al., Standardization of an experimental model suitable for studies on the effect of exercise on arthritis, Einstein São Paulo Braz, vol.11, issue.1, pp.76-82, 2013.

A. Billiau and P. Matthys, Collagen-induced arthritis and related animal models: how much of their pathogenesis is auto-immune, how much is auto-inflammatory?, Cytokine Growth Factor Rev, vol.22, issue.5-6, pp.339-344, 2011.

E. Schurgers, A. Billiau, and P. Matthys, Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-?, J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res, vol.31, issue.12, pp.917-926, 2011.

C. Prati, A. Berthelot, B. Kantelip, D. Wendling, and C. Demougeot, Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis, Arthritis Res Ther, vol.14, issue.3, p.130, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00727649

P. Totoson, K. Maguin-gaté, M. Nappey, D. Wendling, and C. Demougeot, Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation, PloS One, vol.11, issue.1, p.146744, 2016.

Y. Zhang, X. Luo, and Y. Zhou, 2K1C-activated Angiotensin II (Ang II) exacerbates vascular damage in a rat model of arthritis through the ATR/ERK1/2 signaling pathway, Inflamm Res Off J Eur Histamine Res Soc Al, vol.66, issue.10, pp.881-890, 2017.

P. Zochio-tozzato, G. Taipeiro, E. F. Spadella, and M. A. , Collagen-induced arthritis increases inducible nitric oxide synthase not only in aorta but also in the cardiac and renal microcirculation of mice, Clin Exp Immunol, vol.183, issue.3, pp.341-349, 2016.

P. Totoson, K. Maguin-gaté, M. Nappey, C. Prati, D. Wendling et al., Microvascular Abnormalities in Adjuvant-Induced Arthritis: Relationship to Macrovascular Endothelial Function and Markers of Endothelial Activation, Arthritis Rheumatol, vol.67, issue.5, pp.1203-1213, 2015.

K. Hamilton, L. Dunning, W. R. Ferrell, J. C. Lockhart, and A. Mackenzie, Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors, Vascul Pharmacol, vol.100, pp.51-57, 2018.

P. Totoson, K. Maguin-gaté, and A. Prigent-tessier, Etanercept improves endothelial function via pleiotropic effects in rat adjuvant-induced arthritis. Rheumatol Oxf Engl, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01376195

F. Verhoeven, P. Totoson, and K. Maguin-gaté, Glucocorticoids improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis, Clin Exp Immunol, vol.188, issue.2, pp.208-218, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01563702

F. Verhoeven, P. Totoson, and C. Marie, Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: A study in adjuvant-induced arthritis, Atherosclerosis, vol.266, pp.136-144, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01652245

A. Mackenzie, L. Dunning, W. R. Ferrell, and J. C. Lockhart, Angiotensin II Type 1 receptor blockade protects endothelium-derived hyperpolarising factor-mediated relaxation in a rat model of monoarthritis, Life Sci, vol.92, issue.23, pp.1131-1137, 2013.

P. Poredos and M. K. Jezovnik, Testing endothelial function and its clinical relevance, J Atheroscler Thromb, vol.20, issue.1, pp.1-8, 2013.

D. Tousoulis, C. Simopoulou, and N. Papageorgiou, Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches, Pharmacol Ther, vol.144, issue.3, pp.253-267, 2014.

J. Turner, J. Belch, and F. Khan, Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis, Trends Cardiovasc Med, vol.18, issue.4, pp.109-116, 2008.

R. Rubinshtein, J. T. Kuvin, and M. Soffler, Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events, Eur Heart J, vol.31, issue.9, pp.1142-1148, 2010.

P. O. Bonetti, G. M. Pumper, S. T. Higano, D. R. Holmes, J. T. Kuvin et al., Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia, J Am Coll Cardiol, vol.44, issue.11, pp.2137-2141, 2004.

P. Meimoun, Explorer la réserve coronaire par échocardiographie-Doppler transthoracique, Réal Cardiol, issue.292, pp.9-14, 2013.

E. Laugesen, P. Høyem, and J. Fleischer, Reduced Subendocardial Viability Ratio Is Associated With Unfavorable Cardiovascular Risk Profile in Women With Short Duration of Type 2 Diabetes, Am J Hypertens, vol.29, issue.10, pp.1165-1172, 2016.

J. Guan, S. Zhang, Q. Zhou, C. Li, and Z. Lu, Usefulness of Transcranial Doppler Ultrasound in Evaluating Cervical-Cranial Collateral Circulations, Interv Neurol, vol.2, issue.1, pp.8-18, 2013.

Q. Chen, S. Li, G. Lv, and Y. Zhao, Application of Transcranial Color Doppler Ultrasonography for Assessing Middle Cerebral Arteries in Rheumatoid Arthritis, Ultrasound Q, vol.33, issue.4, pp.281-283, 2017.

J. A. Angus and C. E. Wright, Techniques to study the pharmacodynamics of isolated large and small blood vessels, J Pharmacol Toxicol Methods, vol.44, issue.2, pp.395-407, 2000.

R. M. Bryan, M. Y. Eichler, M. Swafford, T. D. Johnson, M. S. Suresh et al., Stimulation of ?2Adrenoceptors Dilates the Rat Middle Cerebral Artery, Anesthesiol J Am Soc Anesthesiol, vol.85, issue.1, pp.82-90, 1996.

C. Heiss, R. E. Sievers, and N. Amabile, In vivo measurement of flow-mediated vasodilation in living rats using high-resolution ultrasound, Am J Physiol Heart Circ Physiol, vol.294, issue.2, pp.1086-1093, 2008.

J. Belch, N. Akbar, V. Alapati, J. Petrie, S. Arthur et al., Longitudinal assessment of endothelial function in the microvasculature of mice in-vivo, Microvasc Res, vol.85, pp.86-92, 2013.

R. Bordy, P. Totoson, C. Prati, C. Marie, D. Wendling et al., Microvascular endothelial dysfunction in rheumatoid arthritis, Nat Rev Rheumatol, vol.14, issue.7, pp.404-420, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01875778

G. L. Erre, G. Buscetta, and P. Paliogiannis, Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis, Rheumatol Int, vol.38, issue.7, pp.1179-1190, 2018.

F. Ursini, P. Ruscitti, G. Caio, R. Manfredini, R. Giacomelli et al., The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review, Autoimmun Rev, 2019.

S. Hänsel, G. Lässig, F. Pistrosch, and J. Passauer, Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity, Atherosclerosis, vol.170, issue.1, pp.177-180, 2003.

A. Guin, C. Adhikari, M. Chakraborty, S. Sinhamahapatra, P. Ghosh et al., Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study, Semin Arthritis Rheum, vol.43, issue.1, pp.48-54, 2013.

S. M. El-gowilly, M. M. Helmy, and H. M. El-gowelli, Pioglitazone ameliorates methotrexate-induced renal endothelial dysfunction via amending detrimental changes in some antioxidant parameters, systemic cytokines and Fas production, Vascul Pharmacol, vol.74, pp.139-150, 2015.

H. Sankrityayan and A. S. Majumdar, Curcumin and folic acid abrogated methotrexate induced vascular endothelial dysfunction, Can J Physiol Pharmacol, vol.94, issue.1, pp.89-96, 2016.

K. Noguchi, N. Hamadate, and T. Matsuzaki, Increasing dihydrobiopterin causes dysfunction of endothelial nitric oxide synthase in rats in vivo, Am J Physiol Heart Circ Physiol, vol.301, issue.3, pp.721-729, 2011.

S. Miriyala, G. Nieto, M. C. Mingone, and C. , Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation, Circulation, vol.113, issue.24, pp.2818-2825, 2006.

F. Cosentino, S. Rubattu, C. Savoia, V. Venturelli, E. Pagannonne et al., Endothelial dysfunction and stroke, J Cardiovasc Pharmacol, vol.38, issue.2, pp.75-78, 2001.

X. Hu, D. Silva, T. M. Chen, J. Faraci, and F. M. , Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke, Circ Res, vol.120, issue.3, pp.449-471, 2017.

M. Pudlo, C. Demougeot, and C. Girard-thernier, Arginase Inhibitors: A Rational Approach Over One Century, Med Res Rev, vol.37, issue.3, pp.475-513, 2017.

U. M. Chandrasekharan, Z. Wang, and Y. Wu, Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis, Arthritis Res Ther, vol.20, issue.1, p.123, 2018.

M. Turiel, F. Atzeni, and L. Tomasoni, Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients, Rheumatol Oxf Engl, vol.48, issue.7, pp.834-839, 2009.

A. Recio-mayoral, J. C. Mason, J. C. Kaski, M. B. Rubens, O. A. Harari et al., Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease, Eur Heart J, vol.30, issue.15, pp.1837-1843, 2009.

L. M. Dooley, E. A. Washington, A. Abdalmula, E. M. Tudor, W. G. Kimpton et al., Endothelial dysfunction in an ovine model of collagen-induced arthritis, J Vasc Res, vol.51, issue.2, pp.90-101, 2014.

Q. Shi, J. Abusarah, G. Baroudi, J. C. Fernandes, H. Fahmi et al., Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis, Arthritis Res Ther, vol.14, issue.5, p.223, 2012.

A. C. Schubert, M. Wendt, and A. B. De-sá-nakanishi, Oxidative state and oxidative metabolism of the heart from rats with adjuvant-induced arthritis, Exp Mol Pathol, vol.100, issue.3, pp.393-401, 2016.

N. Bahaa, A. El-moeim-attia, and A. , Effect of omega-3 on cardiac muscle structure in a model of rheumatoid arthritis in rat. A light and electron microscopic study, Eur J Pharm Med Res, vol.4, issue.8, pp.9-19, 2017.

E. Ho, K. Galougahi, K. Liu, C. Bhindi, R. Figtree et al., Biological markers of oxidative stress: Applications to cardiovascular research and practice, Redox Biol, vol.1, issue.1, pp.483-491, 2013.

V. Loria, I. Dato, F. Graziani, and L. M. Biasucci, Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes, Mediators Inflamm, p.135625, 2008.

J. T. Giles, V. Fernandes, J. Lima, and J. M. Bathon, Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis, Arthritis Res Ther, vol.7, issue.5, pp.195-207, 2005.

J. M. Davis, K. L. Knutson, and M. A. Strausbauch, A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis, Arthritis Rheum, vol.63, issue.6, pp.1497-1506, 2011.

W. Zhang, A. L. Chancey, and H. Tzeng, The Development of Myocardial Fibrosis in Transgenic Mice with Targeted Overexpression of Tumor Necrosis Factor Requires Mast Cell-Fibroblast Interactions, Circulation, vol.124, pp.2106-2116, 2011.

G. Pironti, A. Bersellini-farinotti, and N. M. Agalave, oxidative stress and impaired contractility in a rheumatoid arthritis mouse model, Heart, vol.104, issue.24, pp.2026-2034, 2018.

J. Xu, O. A. Carretero, and Y. Liu, Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice. Hypertens Dallas Tex, vol.40, pp.244-250, 1979.

T. Annussek, T. Szuwart, J. Kleinheinz, C. Koiky, and K. Wermker, In vitro inhibition of HUVECs by low dose methotrexate -insights into oral adverse events, Head Face Med, vol.10, p.19, 2014.

C. J. Merkle, I. Moore, ). Ki, and B. S. Penton, Methotrexate Causes Apoptosis in Postmitotic Endothelial Cells, Biol Res Nurs, vol.2, issue.1, pp.5-14, 2000.

T. Omata, Y. Segawa, N. Inoue, N. Tsuzuike, Y. Itokazu et al., Methotrexate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis, Res Exp Med Z Für Gesamte Exp Med Einschl Exp Chir, vol.197, issue.2, pp.81-90, 1997.

M. J. Crabtree, A. L. Tatham, and Y. Al-wakeel, Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression, J Biol Chem, vol.284, issue.2, pp.1136-1144, 2009.

V. A. Morrow, F. Foufelle, J. Connell, J. R. Petrie, G. W. Gould et al., Direct activation of AMPactivated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells, J Biol Chem, vol.278, issue.34, pp.31629-31639, 2003.

S. U. Simjee, H. Jawed, J. Quadri, and S. A. Saeed, Quantitative gait analysis as a method to assess mechanical hyperalgesia modulated by disease-modifying antirheumatoid drugs in the adjuvant-induced arthritic rat, Arthritis Res Ther, vol.9, issue.5, p.91, 2007.

L. Goff, B. Soltner, E. Charrier, and C. , A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis, Arthritis Res Ther, vol.11, issue.6, p.185, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00663553

S. L. Morgan, J. E. Baggott, W. K. Bernreuter, R. E. Gay, R. Arani et al., MTX affects inflammation and tissue destruction differently in the rat AA model, J Rheumatol, vol.28, issue.7, pp.1476-1481, 2001.

M. Hisadome, T. Fukuda, K. Adachi, and H. Komatsu, Combination benefit of a pyrimidylpiperazine derivative (Y-40138) and methotrexate in arthritic rats, Eur J Pharmacol, vol.497, issue.3, pp.351-359, 2004.

J. E. Baggott, S. L. Morgan, and E. Methotrexate, -hydroxynon-3-yl) Adenine Therapy for Rat Adjuvant Arthritis and the Effect of Methotrexate on In Vivo Purine Metabolism, Eur J Pharm Sci Off J Eur Fed Pharm Sci, vol.31, issue.9, p.206, 2007.

S. E. Bilasy, S. S. Essawy, M. F. Mandour, E. Ali, and S. A. Zaitone, Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis, Pharmacol Rep PR, vol.67, issue.1, pp.102-114, 2015.

J. Tuncel, S. Haag, and M. H. Hoffmann, Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat, PLOS ONE, vol.11, issue.5, p.155936, 2016.

M. Chouk, R. Bordy, J. Moretto, D. Wendling, P. Totoson et al., Pristane-Induced Arthritis in Dark Agouti rat is a relevant model for mimicking vascular dysfunction and lipid paradox in rheumatoid arthritis, Jt Bone Spine Rev Rhum, vol.86, issue.4, pp.483-490, 2019.

P. H. Dessein, R. López-mejias, and C. González-juanatey, Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis, J Rheumatol, vol.41, issue.3, pp.429-436, 2014.

Y. Park, J. Kim, J. Park, J. Choi, W. Kim et al., Bone erosion is associated with reduction of circulating endothelial progenitor cells and endothelial dysfunction in rheumatoid arthritis, Arthritis Rheumatol Hoboken NJ, vol.66, issue.6, pp.1450-1460, 2014.

V. S. Salazar, L. W. Gamer, and V. Rosen, BMP signalling in skeletal development, disease and repair, Nat Rev Endocrinol, vol.12, issue.4, pp.203-221, 2016.

D. Grcevic, Z. Jajic, and N. Kovacic, Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness, J Rheumatol, vol.37, issue.2, pp.246-256, 2010.

A. B. Reiss, S. E. Carsons, and K. Anwar, Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1

, Arthritis Rheum, vol.58, issue.12, pp.3675-3683, 2008.

E. Coomes, E. Chan, and A. B. Reiss, Methotrexate in atherogenesis and cholesterol metabolism, Cholesterol, p.503028, 2011.

F. Vincenzi, M. Padovan, and M. Targa, A2A Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats, PLoS ONE, vol.8, issue.1, 2013.

J. Beinsberger, J. Heemskerk, and J. Cosemans, Chronic arthritis and cardiovascular disease: altered blood parameters give rise to a prothrombotic propensity, Semin Arthritis Rheum, vol.44, issue.3, pp.345-352, 2014.

W. Lai and M. Y. Kan, Homocysteine-Induced Endothelial Dysfunction, Ann Nutr Metab, vol.67, issue.1, pp.1-12, 2015.

R. Deminice and F. T. Rosa, Creatine supplementation decreased homocysteine plasma levels in rats but not humans: A critical review with meta-analysis, J Nutr Intermed Metab, vol.3, pp.50-57, 2016.

K. Schroecksnadel, B. Frick, and S. Kaser, Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis, Clin Chim Acta Int J Clin Chem, vol.338, issue.1-2, pp.157-164, 2003.

K. Schroecksnadel, B. Frick, C. Winkler, F. Leblhuber, B. Wirleitner et al., Hyperhomocysteinemia and immune activation, Clin Chem Lab Med, vol.41, issue.11, pp.1438-1443, 2003.

A. Elkan, N. Håkansson, J. Frostegård, and I. Hafström, Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass--a cross sectional study, BMC Musculoskelet Disord, vol.12, p.13, 2011.

J. Shin, Y. Lee, S. G. Kim, B. Y. Choi, H. Lee et al., The beneficial effects of Tai Chi exercise on endothelial function and arterial stiffness in elderly women with rheumatoid arthritis, Arthritis Res Ther, vol.17, issue.1, p.380, 2015.

S. M. Morris, Recent advances in arginine metabolism: roles and regulation of the arginases, Br J Pharmacol, vol.157, issue.6, 2009.

W. Barakat, A. Fahmy, M. Askar, and S. El-kannishy, Effectiveness of arginase inhibitors against experimentally induced stroke, Naunyn Schmiedebergs Arch Pharmacol, vol.391, issue.6, pp.603-612, 2018.

&. O-sepia and V. B. Lea, Ca A gi ase I hi ito s Be the A s e to The apeutic Challenges i Alzhei e s Disease?, Neurother J Am Soc Exp Neurother, vol.15, issue.4, pp.1032-1035, 2018.

B. Scalera-fortunato, B. Jürgen, and . Bibiana, Endogenous Nitric Oxide Synthesis Inhibitor Asymmetric Dimethyl l-Arginine Accelerates Endothelial Cell Senescence, Arterioscler Thromb Vasc Biol, vol.24, issue.10, pp.1816-1822, 2004.

Y. Xiong, M. F. Fru, Y. Yu, J. Montani, M. et al., Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling, Aging, vol.6, issue.5, pp.369-379, 2014.

S. P. Schulman, L. C. Becker, and D. A. Kass, L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial, JAMA, vol.295, issue.1, pp.58-64, 2006.

J. Moretto, C. Girard, and C. Demougeot, The role of arginase in aging: A systematic review, Exp Gerontol, vol.116, pp.54-73, 2019.

O. Tangphao, M. Grossmann, S. Chalon, B. B. Hoffman, and T. F. Blaschke, Pharmacokinetics of intravenous and oral L-arginine in normal volunteers, Br J Clin Pharmacol, vol.47, issue.3, pp.261-266, 1999.

R. Rygula, N. Abumaria, G. Flügge, E. Fuchs, E. Rüther et al., Anhedonia and motivational deficits in rats: impact of chronic social stress, Behav Brain Res, vol.162, issue.1, pp.127-134, 2005.

L. Niu, J. X. , J. L. Zhang, Y. Liu, B. Li et al., Feasibility of focal cerebral ischemia and reperfusion surgery combined with chronic unpredictable mild stress to simulate the post-stroke depressive state in rats, Behav Brain Funct BBF, vol.11, p.39, 2015.

M. Möller, J. Fourie, and B. H. Harvey, Efavirenz exposure, alone and in combination with known drugs of abuse, engenders addictive-like bio-behavioural changes in rats, Sci Rep, vol.8, issue.1, p.12837, 2018.

S. Singh, M. Fumery, and A. G. Singh, Comparative Risk of Cardiovascular Events with Biologic and Synthetic Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis, Arthritis Care Res, 2019.

C. Tang, Y. F. Huang, C. Chen, and D. , Potential benefits of biologics on stroke and mortality in patients with rheumatoid arthritis: A nationwide population-based cohort study in Taiwan, Int J Rheum Dis, 2019.

M. Matsuda, D. Kishida, and T. Kinoshita, Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis, Intern Med Tokyo Jpn, vol.50, pp.2219-2222, 2011.

I. González-suárez, M. J. Aguilar-amat, M. Trigueros, A. M. Borobia, A. Cruz et al., Leukoencephalopathy due to oral methotrexate, Cerebellum Lond Engl, vol.13, issue.1, pp.178-183, 2014.

D. Wang, S. Hu, and J. Zhu, Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis, J Cell Mol Med, vol.17, issue.12, pp.1577-1587, 2013.

A. Haq, K. El-ramahi, A. Al-dalaan, and A. St, Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis, J Med, vol.30, issue.1-2, pp.51-60, 1999.

M. Pache, H. A. Schwarz, and H. J. Kaiser, Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis, Med Sci Monit Int Med J Exp Clin Res, vol.8, issue.9, pp.616-619, 2002.

Y. Chang and W. Wei, Angiotensin II in inflammation, immunity and rheumatoid arthritis, Clin Exp Immunol, vol.179, issue.2, pp.137-145, 2015.

M. Jankowich and G. Choudhary, Endothelin-1 levels and cardiovascular events, Trends Cardiovasc Med, 2019.

P. Conte-f-de, C. Barja-fidalgo, and W. A. Verri, Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1, J Leukoc Biol, vol.84, issue.3, pp.652-660, 2008.

P. B. Donate, T. M. Cunha, and W. A. Verri, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-? in the induction of endothelin system genes, Inflamm Res Off J Eur Histamine Res Soc Al, vol.61, issue.4, pp.337-348, 2012.

Y. Wang, J. Kou, and H. Zhang, The renin-angiotensin system in the synovium promotes periarticular osteopenia in a rat model of collagen-induced arthritis, Int Immunopharmacol, vol.65, pp.550-558, 2018.

P. P. Sfikakis, C. Papamichael, and K. S. Stamatelopoulos, Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis, Arthritis Rheum, vol.56, issue.6, pp.1985-1993, 2007.

P. J. Kotyla, A. Owczarek, J. Rakoczy, M. Lewicki, E. J. Kucharz et al., Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide, J Rheumatol, vol.39, issue.4, pp.701-706, 2012.

I. Ikonomidis, G. Pavlidis, and P. Katsimbri, Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function, Clin Res Cardiol Off J Ger Card Soc, 2019.

H. Autorité-de-santé, Rappo t d' valuatio tech ologi ue : Evaluatio de l'i age ie cardiaque non invasive dans le diagnostic des coronaropathies chroniques stables, p.127, 2016.

S. L. Lim, C. Lam, V. Segers, D. L. Brutsaert, D. Keulenaer et al., Cardiac endotheliummyocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction, Eur Heart J, vol.36, issue.31, pp.2050-2060, 2015.

C. Sanghera, L. M. Wong, M. Panahi, A. Sintou, M. Hasham et al., Cardiac phenotype in mouse models of systemic autoimmunity, Dis Model Mech, vol.12, issue.3, 2019.

M. Wojciechowska and D. Szukiewicz, The extent of ischemia-reperfusion injury in adjuvant arthritis rats, Recent Researches in Environment and Biomedicine, vol.2012, p.6, 2019.

M. Woj-ie-ho-ska, W. , M. Ciu?-?ska, and G. , zukie icz D. Ischaemic heart preconditioning in rats with adjuvant-induced arthritis, Kardiol Pol, vol.71, issue.8, pp.839-844, 2013.

Y. Kobayashi, H. Kobayashi, M. Hirano, and J. T. Giles, Left Ventricular Regional Dysfunction Using Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients Without Cardiac Symptoms: Comparison Between Methotrexate and Biologics Treatment Groups, J Rheumatol, vol.41, issue.7, pp.1560-1562, 2014.

P. M. Ridker, B. M. Everett, and A. Pradhan, Low-Dose Methotrexate for the Prevention of Atherosclerotic Events, N Engl J Med, vol.380, issue.8, pp.752-762, 2019.

M. Baniaamam, W. J. Paulus, A. B. Blanken, and M. T. Nurmohamed, The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review, Expert Opin Biol Ther, vol.18, issue.5, pp.585-594, 2018.

E. Vizzardi, I. Cavazzana, and F. Franceschini, Left ventricular function in rheumatoid arthritis during anti-TNF-? treatment: a speckle tracking prospective echocardiographic study. Monaldi Arch Chest Dis Arch Monaldi Mal Torace, vol.84, p.716, 2016.

A. Low, D. Symmons, and M. Lunt, Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis, Ann Rheum Dis, vol.76, issue.4, pp.654-660, 2017.

A. Abbate, F. N. Salloum, and E. Vecile, Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction, Circulation, vol.117, issue.20, pp.2670-2683, 2008.

A. Abbate, M. C. Kontos, and J. D. Grizzard, Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study), Am J Cardiol, vol.105, issue.10, pp.1371-1377, 2010.

I. Ikonomidis, S. Tzortzis, and J. Lekakis, Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis, Heart Br Card Soc, vol.95, issue.18, pp.1502-1507, 2009.

M. Hjort, K. M. Eggers, and L. Lindhagen, Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries, Clin Chem, 2019.

Y. Kobayashi, H. Kobayashi, J. T. Giles, M. Hirano, Y. Nakajima et al., Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging, Int J Rheum Dis, vol.19, issue.11, pp.1169-1174, 2016.